Daewoong Pharmaceutical announced Tuesday that it has filed for a domestic patent for a new obesity drug that suppresses ...

The ads promise GLP-1 medications for diabetes and weight loss delivered ... 1st case of new form of mpox in a traveler You ...

With only one approved drug on the market, companies like Inventiva Pharma are advancing MASH drugs and seeking a competitive ...

Rani Therapeutics Holdings, Inc. Class A ( (RANI) ) has released its Q3 earnings. Here is a breakdown of the information Rani Therapeutics ...

In the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking tirzepatide for up to 3 years had a reduced combined risk of worsening heart failure ...

In the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking ...

Eli Lilly is calling it triple G. Meanwhile, the company's orforglipron is an oral GLP-1 medicine, which some patients might ...

Despite semaglutide's quick rise in popularity, more than half of adults who have taken a GLP-1 receptor agonist ... in late ...

Findings suggest semaglutide and other GLP-1 agonists may significantly reduce alcohol use disorder hospitalizations, ...

Preventing a First Stroke May Be Possible With Screening, Lifestyle Changes. Healthy lifestyle behaviors, such as good nutrition, smoking cessation and being p ...

The use of diabetes and weight-loss medications like Ozempic or Wegovy—called GLP-1 drugs—has exploded in recent years, with ...

Drugs already taken by millions of diabetes patients appear to also help slash asthma attacks by up to 70%, new research shows.